SEARCH

SEARCH BY CITATION

References

  • 1
    La Vecchia C,Tavani A,Franceschi S,Levi F,Corrao G,Negri E. Epidemiology and prevention of oral cancer. Oral Oncol 1997; 33: 30212.
  • 2
    La Vecchia C,Lucchini F,Negri E,Levi F. Trends in oral cancer mortality in Europe. Oral Oncol 2004; 40: 4339.
  • 3
    Goldstein AM,Blot WJ,Greenberg RS,Schoenberg JB,Austin DF,Preston-Martin S,Winn DM,Bernstein L,McLaughlin JK,Fraumeni JF,Jr. Familial risk in oral and pharyngeal cancer. Eur J Cancer B Oral Oncol 1994; 30: 31922.
  • 4
    Brown LM,Gridley G,Diehl SR,Winn DM,Harty LC,Otero EB,Fraumeni JF,Jr,Hayes RB. Family cancer history and susceptibility to oral carcinoma in Puerto Rico. Cancer 2001; 92: 21028.
  • 5
    Goldgar DE,Easton DF,Cannon-Albright LA,Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 16008.
  • 6
    Negri E,Franceschi S,Bosetti C,Levi F,Conti E,Parpinel M,La Vecchia C. Selected micronutrients and oral and pharyngeal cancer. Int. J Cancer 2000; 86: 1227.
  • 7
    Levi F,Pasche C,La Vecchia C,Lucchini F,Franceschi S,Monnier P. Food groups and risk of oral and pharyngeal cancer. Int. J Cancer 1998; 77: 7059.
  • 8
    Breslow NE,Day NE. Statistical methods in cancer research, vol. I. The analysis of case-control studies. Lyon: IARC Scientific Publication no. 32, 1980.
  • 9
    Franceschi S,Talamini R,Barra S,Baron AE,Negri E,Bidoli E,Serraino D,La Vecchia C. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 1990; 50: 65027.
  • 10
    Koch M,Gaedke H,Jenkins H. Family history of ovarian cancer patients: a case-control study. Int J Epidemiol 1989; 18: 7825.
  • 11
    Theis B,Boyd N,Lockwood G,Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 1994; 3: 3217.
  • 12
    Eerola H,Blomqvist C,Pukkala E,Pyrhonen S,Nevanlinna H. Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 2000; 36: 11438.
  • 13
    Bravi F,Bosetti C,Negri E,Lagiou P,La Vecchia C. Family history of cancer provided by hospital controls was satisfactorily reliable. J Clin Epidemiol 2007; 60: 1715.
  • 14
    Ankathil R,Mathew A,Joseph F,Nair MK. Is oral cancer susceptibility inherited? Report of five oral cancer families. Eur J Cancer B Oral Oncol 1996; 32: 637.
  • 15
    Tashiro H,Abe K,Tanioka H. Familial occurrence of cancer of the mouth. J Oral Maxillofac Surg 1986; 44: 3223.
  • 16
    Hara H,Ozeki S,Shiratsuchi Y,Tashiro H,Jingu K. Familial occurrence of oral cancer: report of cases. J Oral Maxillofac Surg 1988; 46: 1098102.
  • 17
    Bondy ML,Spitz MR,Halabi S,Fueger JJ,Schantz SP,Sample D,Hsu TC. Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiol Biomarkers Prev 1993; 2: 1036.
  • 18
    Copper MP,Jovanovic A,Nauta JJ,Braakhuis BJ,de Vries N,van der Waal I,Snow GB. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1995; 121: 15760.
  • 19
    Foulkes WD,Brunet JS,Kowalski LP,Narod SA,Franco EL. Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. Int J Cancer 1995; 63: 76973.
  • 20
    Foulkes WD,Brunet JS,Sieh W,Black MJ,Shenouda G,Narod SA. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. Br Med J 1996; 313: 71621.
  • 21
    Yu GP,Zhang ZF,Hsu TC,Spitz MR,Schantz SP. Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett 1999; 146: 93101.
  • 22
    Jefferies S,Eeles R,Goldgar D,A'Hern R,Henk JM,Gore M. The role of genetic factors in predisposition to squamous cell cancer of the head and neck. Br J Cancer 1999; 79: 8657.
  • 23
    Mork J,Moller B,Glattre E. Familial risk in head and neck squamous cell carcinoma diagnosed before the age of 45: a population-based study. Oral Oncol 1999; 35: 3607.
  • 24
    De Andrade M,Amos CI,Foulkes WD. Segregation analysis of squamous cell carcinoma of the head and neck: evidence for a major gene determining risk. Ann Hum Genet 1998; 62: 50510.
  • 25
    Harty LC,Caporaso NE,Hayes RB,Winn DM,Bravo-Otero E,Blot WJ,Kleinman DV,Brown LM,Armenian HK,Fraumeni JF,Jr,Shields PG. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Nat Cancer Inst 1997; 89: 1698705.
  • 26
    Park JY,Schantz SP,Stern JC,Kaur T,Lazarus P. Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk. Pharmacogenetics 1999; 9: 497504.
  • 27
    Jourenkova-Mironova N,Mitrunen K,Bouchardy C,Dayer P,Benhamou S,Hirvonen A. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 2000; 60: 5346.
  • 28
    Oshan AF,Weissler MC,Watson MA,Bell DA. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 18591.
  • 29
    Lewis SJ,Smith GD. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev 2005; 14: 196771.
  • 30
    Sturgis EM,Castillo EJ,Li L,Zheng R,Eicher SA,Clayman GL,Strom SS,Spitz MR,Wei Q. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999; 20: 21259.
  • 31
    Berwick M,Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Nat Cancer Inst 2000; 92: 87497.
  • 32
    Pelucchi C,Gallus S,Garavello W,Bosetti C,La Vecchia C. Alcohol and tobacco use and cancer risk for upper aero-digestive tract and liver. Alcohol Res Health 2006; 29: 1938.
  • 33
    Rothman KJ,Greenland S. Modern epidemiology. Philadelphia: Lippincott-Raven, 1998.
  • 34
    Franceschi S,Levi F,La Vecchia C. Decline in 5-year survival rates for cancer of head and neck. Lancet 1992; 340: 47.